D-Dimer test meets new CLSI H59-A standards for exclusion of pulmonary embolism
Stago has received approval from the US Food and Drug Administration (FDA) for the STA-Liatest D-Di reagent for the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit. FDA requirements for D-dimer assays for exclusion are now based on the new and more restrictive standards established and […]
